Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.

Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, Leverson GE, Bellingham JM, Fernandez LA, Foley DP, Mezrich JD, D'Alessandro AM, Lucey MR.

Am J Transplant. 2011 Mar;11(3):500-10. doi: 10.1111/j.1600-6143.2010.03414.x.

2.

Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.

Ali S, Ormsby A, Shah V, Segovia MC, Kantz KL, Skorupski S, Eisenbrey AB, Mahan M, Huang MA.

Transpl Immunol. 2012 Jan;26(1):62-9. doi: 10.1016/j.trim.2011.08.005. Epub 2011 Sep 1.

PMID:
21907804
3.

Putative antibody-mediated rejection with C4d deposition in HLA-identical, ABO-compatible renal allografts.

Collins AB, Chicano SL, Cornell LD, Tolkoff-Rubin N, Goes NB, Saidman SL, Farrell ML, Cosimi AB, Colvin RB.

Transplant Proc. 2006 Dec;38(10):3427-9.

PMID:
17175293
4.

Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation.

Salah A, Fujimoto M, Yoshizawa A, Yurugi K, Miyagawa-Hayashino A, Sumiyoshi S, Minamiguchi S, Uemoto S, Maekawa T, Haga H.

Liver Transpl. 2014 Feb;20(2):200-9. doi: 10.1002/lt.23789.

5.

Influence of preformed donor-specific antibodies and C4d on early liver allograft function.

Perera MT, Silva MA, Murphy N, Briggs D, Mirza DF, Neil DA.

Scand J Gastroenterol. 2013 Dec;48(12):1444-51. doi: 10.3109/00365521.2013.845795. Epub 2013 Oct 16.

PMID:
24131305
6.

Beyond C4d: the ultrastructural appearances of endothelium in ABO-incompatible renal allografts.

Bröcker V, Pfaffenbach A, Habicht A, Chatzikyrkou C, Kreipe HH, Haller H, Scheffner I, Gwinner W, Zilian E, Immenschuh S, Schwarz A, Horn PA, Heinemann FM, Becker JU.

Nephrol Dial Transplant. 2013 Dec;28(12):3101-9. doi: 10.1093/ndt/gft373. Epub 2013 Sep 29.

PMID:
24081856
7.

Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: diagnostic considerations in the evaluation of liver allografts.

Kozlowski T, Andreoni K, Schmitz J, Hayashi PH, Nickeleit V.

Liver Transpl. 2012 Jun;18(6):641-58. doi: 10.1002/lt.23403.

8.

Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts.

OʼLeary JG, Demetris AJ, Philippe A, Freeman R, Cai J, Heidecke H, Smith C, Hart B, Jennings LW, Catar R, Everly M, Klintmalm GB, Dragun D.

Transplantation. 2017 Oct;101(10):2399-2409. doi: 10.1097/TP.0000000000001853.

PMID:
28665894
9.

Prospective Monitoring of Donor-specific Anti-HLA Antibodies After Intestine/Multivisceral Transplantation: Significance of De Novo Antibodies.

Kubal C, Mangus R, Saxena R, Lobashevsky A, Higgins N, Fridell J, Tector AJ.

Transplantation. 2015 Aug;99(8):e49-56. doi: 10.1097/TP.0000000000000614.

PMID:
25769071
10.

Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.

Lawrence C, Willicombe M, Brookes PA, Santos-Nunez E, Bajaj R, Cook T, Roufosse C, Taube D, Warrens AN.

Transplantation. 2013 Jan 27;95(2):341-6. doi: 10.1097/TP.0b013e3182743cfa.

PMID:
23197178
11.

Vascular deposition of complement C4d is increased in liver allografts with chronic rejection.

Martelius T, Halme L, Arola J, Höckerstedt K, Lautenschlager I.

Transpl Immunol. 2009 Sep;21(4):244-6. doi: 10.1016/j.trim.2009.06.004. Epub 2009 Jun 21.

PMID:
19540918
12.

Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.

Alvarez-Márquez A, Aguilera I, Gentil MA, Caro JL, Bernal G, Fernández Alonso J, Acevedo MJ, Cabello V, Wichmann I, Gonzalez-Escribano MF, Núñez-Roldán A.

Transplantation. 2009 Jan 15;87(1):94-9. doi: 10.1097/TP.0b013e31818bd790.

PMID:
19136897
13.

Probable C4d-negative accelerated acute antibody-mediated rejection due to non-HLA antibodies.

Niikura T, Yamamoto I, Nakada Y, Kamejima S, Katsumata H, Yamakawa T, Furuya M, Mafune A, Kobayashi A, Tanno Y, Miki J, Yamada H, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T.

Nephrology (Carlton). 2015 Jul;20 Suppl 2:75-8. doi: 10.1111/nep.12467. Review.

PMID:
26031592
14.

Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation.

Haga H, Egawa H, Fujimoto Y, Ueda M, Miyagawa-Hayashino A, Sakurai T, Okuno T, Koyanagi I, Takada Y, Manabe T.

Liver Transpl. 2006 Mar;12(3):457-64.

15.

Pretransplant donor-specific anti-HLA antibodies as predictors of early allograft rejection in ABO-compatible liver transplantation.

Musat AI, Pigott CM, Ellis TM, Agni RM, Leverson GE, Powell AJ, Richards KR, D'Alessandro AM, Lucey MR.

Liver Transpl. 2013 Oct;19(10):1132-41. doi: 10.1002/lt.23707. Epub 2013 Aug 15.

16.

Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification.

Mauiyyedi S, Crespo M, Collins AB, Schneeberger EE, Pascual MA, Saidman SL, Tolkoff-Rubin NE, Williams WW, Delmonico FL, Cosimi AB, Colvin RB.

J Am Soc Nephrol. 2002 Mar;13(3):779-87.

17.

Significance of C4d staining in ABO-identical/compatible liver transplantation.

Sakashita H, Haga H, Ashihara E, Wen MC, Tsuji H, Miyagawa-Hayashino A, Egawa H, Takada Y, Maekawa T, Uemoto S, Manabe T.

Mod Pathol. 2007 Jun;20(6):676-84. Epub 2007 Apr 13.

18.

C4d-positive interacinar capillaries correlates with donor-specific antibody-mediated rejection in pancreas allografts.

Torrealba JR, Samaniego M, Pascual J, Becker Y, Pirsch J, Sollinger H, Odorico J.

Transplantation. 2008 Dec 27;86(12):1849-56. doi: 10.1097/TP.0b013e3181902319.

PMID:
19104433
19.

Clinical and pathological analyses of transplant glomerulopathy cases.

Shimizu T, Ishida H, Toki D, Nozaki T, Omoto K, Tanabe K, Honda K, Koike J.

Nephrology (Carlton). 2014 Jun;19 Suppl 3:21-6. doi: 10.1111/nep.12243.

PMID:
24842817
20.

C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts.

Haas M, Segev DL, Racusen LC, Bagnasco SM, Locke JE, Warren DS, Simpkins CE, Lepley D, King KE, Kraus ES, Montgomery RA.

J Am Soc Nephrol. 2009 Jan;20(1):197-204. doi: 10.1681/ASN.2008030279. Epub 2008 Sep 5.

Supplemental Content

Support Center